Market Scope

Trusted Partner of Industry and Medical Professionals for Market Data, Primary Research, Independent Perspective, & Objective Analysis

Latest Reports Latest News

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

10/15/2021
AllergyBreakingCataractPharmaRegulation
US FDA Expands Labeling for Dextenza to Include Allergic Ocular Itching
US FDA Expands Labeling for Dextenza to Include Allergic Ocular Itching

Ocular Therapeutix announced Oct. 11 that the US FDA had approved its supplemental new drug application (sNDA) to add an indication for Dextenza for the treatment of ocular itching associated with ...

10/15/2021
BreakingDry EyePharmaRegulation
Allergan Agrees to $30 Million Settlement with Restasis End Payors
Allergan Agrees to $30 Million Settlement with Restasis End Payors

Allergan, now part of AbbVie, has agreed to a $30 million settlement to end part of a class action lawsuit involving end payors (such as insurers, pharmacy benefit managers, and pension funds) that...

10/15/2021
BreakingPharmaRegulationRetina
EMA Accepts Marketing Application for Lucentis Biosimilar from Xbrane, Stada
EMA Accepts Marketing Application for Lucentis Biosimilar from Xbrane, Stada

Sweden’s Xbrane Biopharma and its partner Stada, of Germany, announced Sept. 30 that the European Medicines Agency (EMA) had accepted the marketing authorization application (MAA) for their ranibiz...

10/15/2021
BreakingDealsIndiaSurgical
Dr. Agarwals Eye Hospitals Adds 100th Center as it Plans $133 Million Expansion in India
Dr. Agarwals Eye Hospitals Adds 100th Center as it Plans $133 Million Expansion in India

Dr. Agarwals Eye Hospitals will invest more than US $133 million over the next three years to increase its footprint across India to 200 hospitals and 500 outreach centers, India’s ETHealthWorld re...

10/15/2021
BreakingGene TherapyRegulationRetina
US FDA Clears IND for 4DMT’s Wet AMD Gene Therapy Candidate
US FDA Clears IND for 4DMT’s Wet AMD Gene Therapy Candidate

4D Molecular Therapeutics announced Oct. 6 that the US FDA had cleared the investigational new drug application (IND) for 4D-150 for wet age-related macular degeneration (wet AMD). 4D-150 is a dual...

10/15/2021
BreakingDealsGene TherapyRetina
Intellia, SparingVision to Collaborate on Ocular Therapies Using CRISPR/Cas9 Technology
Intellia, SparingVision to Collaborate on Ocular Therapies Using CRISPR/Cas9 Technology

Intellia Therapeutics, of Cambridge, Massachusetts, announced Oct. 13 a strategic collaboration with France’s SparingVision to develop ocular therapies utilizing CRISPR/Cas9 technology. Intellia wi...

10/15/2021
BreakingRefractiveSurgical
Zeiss’ SMILE Procedures Top 5 Million
Zeiss’ SMILE Procedures Top 5 Million

German company Zeiss announced Oct. 11 that ophthalmologists had performed more than 5 million SMILE procedures. Based on Zeiss’ previous announcements of SMILE milestones, surgeons appear to be pe...

10/15/2021
BreakingGene TherapyRegulationRetina
US FDA Grants Fast Track Status to GenSight’s Optogenetic Therapy Candidate for RP
US FDA Grants Fast Track Status to GenSight’s Optogenetic Therapy Candidate for RP

France-based GenSight Biologics announced Oct. 12 that the US FDA had granted Fast Track Designation to its candidate GS030, which combines AAV2-based gene therapy with optogenetics to treat retini...

Physician Surveys

For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.

Complete a Survey

On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.

Benchmark Your Performance

Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.

View Market Insights & Analytics

Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.

Learn More Register Today

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Join Market Scope Today

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

United States
US Surveys
May select more than one